Sagesse Bio, Inc.
PrivateLast Round
Joint Venture
Jul 31, 2024
Company Overview
Sagesse Bio, Inc. is a biotechnology company that develops RNAi therapeutic products for focal fat reduction and aesthetic body contouring.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sagesse Bio, Inc. Comparables
Compare Sagesse Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Leios Therapeutics | 88% | |
| Amalfi Bio, Inc. | 84% | |
| Raziel Therapeutics | 83% |
Sagesse Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Joint Venture | Jul 31, 2024 |
Sagesse Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gore Range Capital | Joint Venture |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 31, 2024
Gore Range Capital and Sirnaomics participated in the round.
Sagesse Bio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sagesse Bio, Inc.'s valuation, stock price, and market status.
Is Sagesse Bio, Inc. a public or private company?
Sagesse Bio, Inc. is a private company.
What is the current stock price of Sagesse Bio, Inc.?
Sagesse Bio, Inc. is a private company, so its shares have no public market price. Caplight tracks Sagesse Bio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sagesse Bio, Inc. worth (valuation)?
Valuation information for Sagesse Bio, Inc. is not publicly available.
Can I buy Sagesse Bio, Inc. stock?
Sagesse Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sagesse Bio, Inc.'s last funding round?
Sagesse Bio, Inc.'s most recent funding round was Joint Venture on July 31, 2024.
Who are the main investors in Sagesse Bio, Inc.?
Key investors in Sagesse Bio, Inc. include Gore Range Capital.
Will Sagesse Bio, Inc. IPO soon?
No public IPO plans have been announced for Sagesse Bio, Inc..
How can I track Sagesse Bio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Sagesse Bio, Inc.'s shares on secondary markets.